Cargando…

P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study

Squamous cell carcinoma of the penis is a rare but often aggressive disease. A large proportion of penile cancers are associated with HPV infection, mainly with HPV high-risk subtypes 16 and 18. From other HPV-related malignancies a link between a functional SNP in the p53 gene (rs1042522, p.Arg72Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoehr, Robert, Weisser, Rebecca, Wendler, Olaf, Giedl, Johannes, Daifalla, Khalid, Gaisa, Nadine T., Richter, Georg, Campean, Valentina, Burger, Maximilian, Wullich, Bernd, Hartmann, Arndt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277628/
https://www.ncbi.nlm.nih.gov/pubmed/30519324
http://dx.doi.org/10.7150/jca.26050
_version_ 1783378191599009792
author Stoehr, Robert
Weisser, Rebecca
Wendler, Olaf
Giedl, Johannes
Daifalla, Khalid
Gaisa, Nadine T.
Richter, Georg
Campean, Valentina
Burger, Maximilian
Wullich, Bernd
Hartmann, Arndt
author_facet Stoehr, Robert
Weisser, Rebecca
Wendler, Olaf
Giedl, Johannes
Daifalla, Khalid
Gaisa, Nadine T.
Richter, Georg
Campean, Valentina
Burger, Maximilian
Wullich, Bernd
Hartmann, Arndt
author_sort Stoehr, Robert
collection PubMed
description Squamous cell carcinoma of the penis is a rare but often aggressive disease. A large proportion of penile cancers are associated with HPV infection, mainly with HPV high-risk subtypes 16 and 18. From other HPV-related malignancies a link between a functional SNP in the p53 gene (rs1042522, p.Arg72Pro) and a higher disease risk in the presence of HPV is documented. The p53 p.Arg72 variant was described as a risk factor for developing a malignancy in combination with the presence of HPV as the p.72Arg variant is more prone to HPV E6 protein-mediated degradation than the p.72Pro variant. For penile carcinoma there are only sparse data available on this topic. We therefore analyzed the distribution of this p53 codon 72 SNP in a cohort of 107 penile cancer patients and a healthy control group (n=194) using Restriction Fragment Length Polymorphism (RFLP) analysis. After DNA isolation a PCR amplicon including the variant nucleotide was generated. Based on the variant nucleotide this amplicon can be cleaved into two parts or remain unaffected by a restriction enzyme. Subsequent electrophoresis allowed the discrimination of SNP alleles in the investigated sample. Comparison of the allelic variants revealed no significant differences in the distribution of this SNP between cases and controls (p=0,622). There was also no difference in SNP distribution between cases with/without HPV infection (p=0,558) or histologic variants (p=0.339). In order to strengthen the impact of our data we performed a combined analysis of all published data on this topic with our results. This ended up in SNP distribution data from 177 cases and 1149 controls. Overall, there were also no significant differences in the allelic distribution of the p53 codon 72 SNP between either cases and controls (p=0,914) or HPV-positive and HPV-negative cases (p=0,486). From this most comprehensive data available to date we conclude that there is no influence of the p53 codon 72 SNP on the risk of development of penile carcinoma in Caucasians even in the presence of HPV.
format Online
Article
Text
id pubmed-6277628
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-62776282018-12-05 P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study Stoehr, Robert Weisser, Rebecca Wendler, Olaf Giedl, Johannes Daifalla, Khalid Gaisa, Nadine T. Richter, Georg Campean, Valentina Burger, Maximilian Wullich, Bernd Hartmann, Arndt J Cancer Research Paper Squamous cell carcinoma of the penis is a rare but often aggressive disease. A large proportion of penile cancers are associated with HPV infection, mainly with HPV high-risk subtypes 16 and 18. From other HPV-related malignancies a link between a functional SNP in the p53 gene (rs1042522, p.Arg72Pro) and a higher disease risk in the presence of HPV is documented. The p53 p.Arg72 variant was described as a risk factor for developing a malignancy in combination with the presence of HPV as the p.72Arg variant is more prone to HPV E6 protein-mediated degradation than the p.72Pro variant. For penile carcinoma there are only sparse data available on this topic. We therefore analyzed the distribution of this p53 codon 72 SNP in a cohort of 107 penile cancer patients and a healthy control group (n=194) using Restriction Fragment Length Polymorphism (RFLP) analysis. After DNA isolation a PCR amplicon including the variant nucleotide was generated. Based on the variant nucleotide this amplicon can be cleaved into two parts or remain unaffected by a restriction enzyme. Subsequent electrophoresis allowed the discrimination of SNP alleles in the investigated sample. Comparison of the allelic variants revealed no significant differences in the distribution of this SNP between cases and controls (p=0,622). There was also no difference in SNP distribution between cases with/without HPV infection (p=0,558) or histologic variants (p=0.339). In order to strengthen the impact of our data we performed a combined analysis of all published data on this topic with our results. This ended up in SNP distribution data from 177 cases and 1149 controls. Overall, there were also no significant differences in the allelic distribution of the p53 codon 72 SNP between either cases and controls (p=0,914) or HPV-positive and HPV-negative cases (p=0,486). From this most comprehensive data available to date we conclude that there is no influence of the p53 codon 72 SNP on the risk of development of penile carcinoma in Caucasians even in the presence of HPV. Ivyspring International Publisher 2018-10-20 /pmc/articles/PMC6277628/ /pubmed/30519324 http://dx.doi.org/10.7150/jca.26050 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Stoehr, Robert
Weisser, Rebecca
Wendler, Olaf
Giedl, Johannes
Daifalla, Khalid
Gaisa, Nadine T.
Richter, Georg
Campean, Valentina
Burger, Maximilian
Wullich, Bernd
Hartmann, Arndt
P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study
title P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study
title_full P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study
title_fullStr P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study
title_full_unstemmed P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study
title_short P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study
title_sort p53 codon 72 polymorphism and risk for squamous cell carcinoma of the penis: a caucasian case-control study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277628/
https://www.ncbi.nlm.nih.gov/pubmed/30519324
http://dx.doi.org/10.7150/jca.26050
work_keys_str_mv AT stoehrrobert p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT weisserrebecca p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT wendlerolaf p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT giedljohannes p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT daifallakhalid p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT gaisanadinet p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT richtergeorg p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT campeanvalentina p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT burgermaximilian p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT wullichbernd p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy
AT hartmannarndt p53codon72polymorphismandriskforsquamouscellcarcinomaofthepenisacaucasiancasecontrolstudy